Literature DB >> 30962283

H2O2 induces nuclear transport of the receptor tyrosine kinase c-MET in breast cancer cells via a membrane-bound retrograde trafficking mechanism.

Mei-Kuang Chen1,2, Yi Du2, Linlin Sun2,3, Jennifer L Hsu2, Yu-Han Wang2,4, Yuan Gao2,5, Jiaxing Huang2,6, Mien-Chie Hung7,2,4,8.   

Abstract

Reactive oxygen species (ROS) are cellular by-products produced from metabolism and also anticancer agents, such as ionizing irradiation and chemotherapy drugs. The ROS H2O2 has high rates of production in cancer cells because of their rapid proliferation. ROS oxidize DNA, protein, and lipids, causing oxidative stress in cancer cells and making them vulnerable to other stresses. Therefore, cancer cell survival relies on maintaining ROS-induced stress at tolerable levels. Hepatocyte growth factor receptor (c-MET) is a receptor tyrosine kinase overexpressed in malignant cancer types, including breast cancer. Full-length c-MET triggers a signal transduction cascade from the plasma membrane that, through downstream signaling proteins, up-regulates cell proliferation and migration. Recently, c-MET was shown to interact and phosphorylate poly(ADP-ribose) polymerase 1 in the nucleus and to induce poly(ADP-ribose) polymerase inhibitor resistance. However, it remains unclear how c-MET moves from the cell membrane to the nucleus. Here, we demonstrate that H2O2 induces retrograde transport of membrane-associated full-length c-MET into the nucleus of human MCF10A and MCF12A or primary breast cancer cells. We further show that knocking down either coatomer protein complex subunit γ1 (COPG1) or Sec61 translocon β subunit (SEC61β) attenuates the accumulation of full-length nuclear c-MET. However, a c-MET kinase inhibitor did not block nuclear c-MET transport. Moreover, nuclear c-MET interacted with KU proteins in breast cancer cells, suggesting a role of full-length nuclear c-MET in ROS-induced DNA damage repair. We conclude that a membrane-bound retrograde vesicle transport mechanism facilitates membrane-to-nucleus transport of c-MET in breast cancer cells.
© 2019 Chen et al.

Entities:  

Keywords:  breast cancer; c-MET; hepatocyte growth factor receptor (HGFR); hydrogen peroxide; nuclear transport; nucleus; reactive oxygen species (ROS); receptor tyrosine kinase; vesicle trafficking

Mesh:

Substances:

Year:  2019        PMID: 30962283      PMCID: PMC6544865          DOI: 10.1074/jbc.RA118.005953

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

1.  Met, the hepatocyte growth factor receptor, localizes to the nucleus in cells at low density.

Authors:  Sharon Pozner-Moulis; Derek J Pappas; David L Rimm
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

2.  Distinct signaling pathways respond to arsenite and reactive oxygen species in Schizosaccharomyces pombe.

Authors:  Miguel A Rodríguez-Gabriel; Paul Russell
Journal:  Eukaryot Cell       Date:  2005-08

Review 3.  All kinesin superfamily protein, KIF, genes in mouse and human.

Authors:  H Miki; M Setou; K Kaneshiro; N Hirokawa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

4.  Clinicopathological relevance of kinesin family member 18A expression in invasive breast cancer.

Authors:  Mai Kasahara; Makoto Nagahara; Tsuyoshi Nakagawa; Toshiaki Ishikawa; Takanobu Sato; Hiroyuki Uetake; Kenichi Sugihara
Journal:  Oncol Lett       Date:  2016-07-07       Impact factor: 2.967

5.  Comparison of biological effects of DNA damage induced by ionizing radiation and hydrogen peroxide in CHO cells.

Authors:  J Dahm-Daphi; C Sass; W Alberti
Journal:  Int J Radiat Biol       Date:  2000-01       Impact factor: 2.694

Review 6.  Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges.

Authors:  Conor A Bradley; Manuel Salto-Tellez; Pierre Laurent-Puig; Alberto Bardelli; Christian Rolfo; Josep Tabernero; Hajrah A Khawaja; Mark Lawler; Patrick G Johnston; Sandra Van Schaeybroeck
Journal:  Nat Rev Clin Oncol       Date:  2017-04-04       Impact factor: 66.675

7.  Biosynthesis of the protein encoded by the c-met proto-oncogene.

Authors:  S Giordano; M F Di Renzo; R P Narsimhan; C S Cooper; C Rosa; P M Comoglio
Journal:  Oncogene       Date:  1989-11       Impact factor: 9.867

8.  Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2.

Authors:  Shao-Chun Wang; Huang-Chun Lien; Weiya Xia; I-Fen Chen; Hui-Wen Lo; Zhiqin Wang; Mohamed Ali-Seyed; Dung-Fang Lee; Geoffrey Bartholomeusz; Fu Ou-Yang; Dipak K Giri; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2004-09       Impact factor: 31.743

9.  Syntaxin 6-mediated Golgi translocation plays an important role in nuclear functions of EGFR through microtubule-dependent trafficking.

Authors:  Y Du; J Shen; J L Hsu; Z Han; M-C Hsu; C-C Yang; H-P Kuo; Y-N Wang; H Yamaguchi; S A Miller; M-C Hung
Journal:  Oncogene       Date:  2013-02-04       Impact factor: 9.867

10.  Overexpression of Kinesin Associated Protein 3 (KIFAP3) in Breast Cancer.

Authors:  Deepthi Telikicherla; Jagadeesha Maharudraiah; Harsh Pawar; Arivusudar Marimuthu; Manoj Kumar Kashyap; Y L Ramachandra; Juan Carlos Roa; Akhilesh Pandey
Journal:  J Proteomics Bioinform       Date:  2012-05-28
View more
  5 in total

1.  Nuclear translocation of the receptor tyrosine kinase c-MET reduces the treatment efficacies of olaparib and gemcitabine in pancreatic ductal adenocarcinoma cells.

Authors:  Yuan Gao; Mei-Kuang Chen; Yu-Yi Chu; Liuqing Yang; Dihua Yu; Yingbin Liu; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2021-01-01       Impact factor: 6.166

2.  Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by MET Inhibition.

Authors:  Concetta D'Ambrosio; Jessica Erriquez; Sonia Capellero; Simona Cignetto; Maria Alvaro; Eric Ciamporcero; Maria Flavia Di Renzo; Timothy Perera; Giorgio Valabrega; Martina Olivero
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

3.  Genomic Action of Sigma-1 Receptor Chaperone Relates to Neuropathic Pain.

Authors:  Shao-Ming Wang; Nino Goguadze; Yuriko Kimura; Yuko Yasui; Bin Pan; Tzu-Yun Wang; Yoki Nakamura; Yu-Ting Lin; Quinn H Hogan; Katherine L Wilson; Tsung-Ping Su; Hsiang-En Wu
Journal:  Mol Neurobiol       Date:  2021-01-18       Impact factor: 5.590

Review 4.  Therapeutic Strategies and Biomarkers to Modulate PARP Activity for Targeted Cancer Therapy.

Authors:  Naveen Singh; S Louise Pay; Snehal B Bhandare; Udhaya Arimpur; Edward A Motea
Journal:  Cancers (Basel)       Date:  2020-04-14       Impact factor: 6.639

Review 5.  Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk.

Authors:  Khadijeh Barzaman; Rana Vafaei; Mitra Samadi; Mohammad Hossein Kazemi; Aysooda Hosseinzadeh; Parnaz Merikhian; Shima Moradi-Kalbolandi; Mohammad Reza Eisavand; Houra Dinvari; Leila Farahmand
Journal:  Cancer Cell Int       Date:  2022-08-19       Impact factor: 6.429

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.